Seikagaku says JAMA Surgery publishes Japan trial results for SI-449 cs barrier adhesion device

Bitget2026/09/29 02:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Seikagaku reported publication of Japan clinical trial results for its SI-449 adhesion barrier, marketed as cs barrierⓇ.
Results were already presented via an article published in JAMA Surgery on Aug. 26, 2026.
Study supported efficacy in open rectal resection, with safety outcomes consistent with use as a surgical adhesion barrier.
Publication may strengthen clinical adoption prospects, supporting commercialization strategy for the product in surgical settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seikagaku Corporation published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Seikagaku says JAMA Surgery publishes Japan trial results for SI-449 cs barrier adhesion device

You may also like

Crypto prices